Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice

Rieko Miyamoto, Mayumi Jijiwa, Masato Asai, Kumi Kawai, Maki Ishida-Takagishi, Shinji Mii, Naoya Asai, Atsushi Enomoto, Yoshiki Murakumo, Akihiko Yoshimura, Masahide Takahashi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The glial cell line-derived neurotrophic factor (GDNF)/RET tyrosine kinase signaling pathway plays crucial roles in the development of the enteric nervous system (ENS) and the kidney. Tyrosine 1062 (Y1062) in RET is an autophosphorylation residue that is responsible for the activation of the PI3K/AKT and RAS/MAPK signaling pathways. Mice lacking signaling via Ret Y1062 show renal hypoplasia and hypoganglionosis of the ENS although the phenotype is milder than the Gdnf- or Ret-deficient mice. Sprouty2 (Spry2) was found to be an antagonist for fibroblast growth factor receptor (FGFR) and acts as an inhibitory regulator of ERK activation. Spry2-deficient mice exhibit hearing loss and enteric nerve hyperplasia. In the present study, we generated Spry2-deficient and Ret Y1062F knock-in (tyrosine 1062 is replaced with phenylalanine) double mutant mice to see if abnormalities of the ENS and kidney, caused by loss of signaling via Ret Y1062, are rescued by a deficiency of Spry2. Double mutant mice showed significant recovery of ureteric bud branching and ENS development in the stomach. These results indicate that Spry2 regulates downstream signaling mediated by GDNF/RET signaling complex in vivo.

Original languageEnglish
Pages (from-to)160-168
Number of pages9
JournalDevelopmental Biology
Volume349
Issue number2
DOIs
Publication statusPublished - 2011 Jan 15

Fingerprint

Enteric Nervous System
Stomach
Kidney
Glial Cell Line-Derived Neurotrophic Factor
Tyrosine
Fibroblast Growth Factor Receptors
Phenylalanine
Phosphatidylinositol 3-Kinases
Hearing Loss
Protein-Tyrosine Kinases
Hyperplasia
Phenotype

Keywords

  • Enteric nervous system
  • RET tyrosine kinase
  • Signal transduction
  • Sprouty2
  • Ureteric bud branching

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology
  • Molecular Biology

Cite this

Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice. / Miyamoto, Rieko; Jijiwa, Mayumi; Asai, Masato; Kawai, Kumi; Ishida-Takagishi, Maki; Mii, Shinji; Asai, Naoya; Enomoto, Atsushi; Murakumo, Yoshiki; Yoshimura, Akihiko; Takahashi, Masahide.

In: Developmental Biology, Vol. 349, No. 2, 15.01.2011, p. 160-168.

Research output: Contribution to journalArticle

Miyamoto, R, Jijiwa, M, Asai, M, Kawai, K, Ishida-Takagishi, M, Mii, S, Asai, N, Enomoto, A, Murakumo, Y, Yoshimura, A & Takahashi, M 2011, 'Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice', Developmental Biology, vol. 349, no. 2, pp. 160-168. https://doi.org/10.1016/j.ydbio.2010.11.002
Miyamoto, Rieko ; Jijiwa, Mayumi ; Asai, Masato ; Kawai, Kumi ; Ishida-Takagishi, Maki ; Mii, Shinji ; Asai, Naoya ; Enomoto, Atsushi ; Murakumo, Yoshiki ; Yoshimura, Akihiko ; Takahashi, Masahide. / Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice. In: Developmental Biology. 2011 ; Vol. 349, No. 2. pp. 160-168.
@article{4568ff2d88b0420eb334e79c8edcee6f,
title = "Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice",
abstract = "The glial cell line-derived neurotrophic factor (GDNF)/RET tyrosine kinase signaling pathway plays crucial roles in the development of the enteric nervous system (ENS) and the kidney. Tyrosine 1062 (Y1062) in RET is an autophosphorylation residue that is responsible for the activation of the PI3K/AKT and RAS/MAPK signaling pathways. Mice lacking signaling via Ret Y1062 show renal hypoplasia and hypoganglionosis of the ENS although the phenotype is milder than the Gdnf- or Ret-deficient mice. Sprouty2 (Spry2) was found to be an antagonist for fibroblast growth factor receptor (FGFR) and acts as an inhibitory regulator of ERK activation. Spry2-deficient mice exhibit hearing loss and enteric nerve hyperplasia. In the present study, we generated Spry2-deficient and Ret Y1062F knock-in (tyrosine 1062 is replaced with phenylalanine) double mutant mice to see if abnormalities of the ENS and kidney, caused by loss of signaling via Ret Y1062, are rescued by a deficiency of Spry2. Double mutant mice showed significant recovery of ureteric bud branching and ENS development in the stomach. These results indicate that Spry2 regulates downstream signaling mediated by GDNF/RET signaling complex in vivo.",
keywords = "Enteric nervous system, RET tyrosine kinase, Signal transduction, Sprouty2, Ureteric bud branching",
author = "Rieko Miyamoto and Mayumi Jijiwa and Masato Asai and Kumi Kawai and Maki Ishida-Takagishi and Shinji Mii and Naoya Asai and Atsushi Enomoto and Yoshiki Murakumo and Akihiko Yoshimura and Masahide Takahashi",
year = "2011",
month = "1",
day = "15",
doi = "10.1016/j.ydbio.2010.11.002",
language = "English",
volume = "349",
pages = "160--168",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice

AU - Miyamoto, Rieko

AU - Jijiwa, Mayumi

AU - Asai, Masato

AU - Kawai, Kumi

AU - Ishida-Takagishi, Maki

AU - Mii, Shinji

AU - Asai, Naoya

AU - Enomoto, Atsushi

AU - Murakumo, Yoshiki

AU - Yoshimura, Akihiko

AU - Takahashi, Masahide

PY - 2011/1/15

Y1 - 2011/1/15

N2 - The glial cell line-derived neurotrophic factor (GDNF)/RET tyrosine kinase signaling pathway plays crucial roles in the development of the enteric nervous system (ENS) and the kidney. Tyrosine 1062 (Y1062) in RET is an autophosphorylation residue that is responsible for the activation of the PI3K/AKT and RAS/MAPK signaling pathways. Mice lacking signaling via Ret Y1062 show renal hypoplasia and hypoganglionosis of the ENS although the phenotype is milder than the Gdnf- or Ret-deficient mice. Sprouty2 (Spry2) was found to be an antagonist for fibroblast growth factor receptor (FGFR) and acts as an inhibitory regulator of ERK activation. Spry2-deficient mice exhibit hearing loss and enteric nerve hyperplasia. In the present study, we generated Spry2-deficient and Ret Y1062F knock-in (tyrosine 1062 is replaced with phenylalanine) double mutant mice to see if abnormalities of the ENS and kidney, caused by loss of signaling via Ret Y1062, are rescued by a deficiency of Spry2. Double mutant mice showed significant recovery of ureteric bud branching and ENS development in the stomach. These results indicate that Spry2 regulates downstream signaling mediated by GDNF/RET signaling complex in vivo.

AB - The glial cell line-derived neurotrophic factor (GDNF)/RET tyrosine kinase signaling pathway plays crucial roles in the development of the enteric nervous system (ENS) and the kidney. Tyrosine 1062 (Y1062) in RET is an autophosphorylation residue that is responsible for the activation of the PI3K/AKT and RAS/MAPK signaling pathways. Mice lacking signaling via Ret Y1062 show renal hypoplasia and hypoganglionosis of the ENS although the phenotype is milder than the Gdnf- or Ret-deficient mice. Sprouty2 (Spry2) was found to be an antagonist for fibroblast growth factor receptor (FGFR) and acts as an inhibitory regulator of ERK activation. Spry2-deficient mice exhibit hearing loss and enteric nerve hyperplasia. In the present study, we generated Spry2-deficient and Ret Y1062F knock-in (tyrosine 1062 is replaced with phenylalanine) double mutant mice to see if abnormalities of the ENS and kidney, caused by loss of signaling via Ret Y1062, are rescued by a deficiency of Spry2. Double mutant mice showed significant recovery of ureteric bud branching and ENS development in the stomach. These results indicate that Spry2 regulates downstream signaling mediated by GDNF/RET signaling complex in vivo.

KW - Enteric nervous system

KW - RET tyrosine kinase

KW - Signal transduction

KW - Sprouty2

KW - Ureteric bud branching

UR - http://www.scopus.com/inward/record.url?scp=78650809394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650809394&partnerID=8YFLogxK

U2 - 10.1016/j.ydbio.2010.11.002

DO - 10.1016/j.ydbio.2010.11.002

M3 - Article

VL - 349

SP - 160

EP - 168

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 2

ER -